Adria Berry, Oklahoma's top medical marijuana regulator, resigned this week after overseeing a dramatic contraction in what was once one of the nation's most permissive cannabis markets.
Berry served as director of the Oklahoma Medical Marijuana Authority since 2021, a period that saw the state's cannabis industry shrink from its peak of more than 9,000 licensed dispensaries to roughly 2,000 today. The market now generates approximately $600 million annually, down from highs exceeding $1 billion.
The timing of Berry's departure raises questions about the future direction of Oklahoma's medical program. State officials have not yet announced a replacement or outlined plans for the agency's leadership transition.
The Regulatory Challenge
Oklahoma launched its medical marijuana program in 2018 with some of the loosest regulations in the country. Patients could obtain cards with minimal requirements, and licensing fees were low. The result was explosive growth that attracted operators from across the nation.
But that growth proved unsustainable. Oversupply drove wholesale prices down, forcing many businesses to close. The state also faced persistent problems with illegal operations and out-of-state investment that violated residency requirements.
Berry's tenure focused heavily on enforcement and compliance. The OMMA increased inspections, revoked hundreds of licenses for violations, and worked with law enforcement to shut down illicit operations. Those efforts, while necessary for market stabilization, coincided with the industry's sharp contraction.
What Operators Are Saying
Industry representatives acknowledge the difficult position Berry faced. "She inherited a Wild West situation," said one Oklahoma dispensary owner who requested anonymity. "The crackdown was inevitable, but it definitely changed the business environment."
Other operators point to broader market forces beyond regulatory control. Competition from neighboring states with adult-use programs, including Missouri and Arkansas's evolving medical market, has pulled customers and investment away from Oklahoma.
The state's medical-only model also limits growth potential. While Oklahoma voters rejected adult-use legalization in 2022, some industry advocates believe recreational sales represent the only path to market expansion.
Budget Pressures Mount
The OMMA operates on a self-funded model, relying entirely on licensing fees and application revenues. As the number of active licenses has dropped, so has the agency's budget. The authority's annual revenue fell from roughly $40 million in 2021 to an estimated $25 million in 2024.
Those budget constraints have limited the agency's ability to hire staff and modernize systems. Some license renewals and applications have faced processing delays, frustrating operators trying to maintain compliance.
State lawmakers have shown little appetite for supplementing the OMMA's budget with general funds, leaving the agency dependent on an industry that continues to consolidate.
Looking Ahead
Berry's successor will inherit several pressing challenges. The agency must balance continued enforcement against the risk of over-regulation that could push more operators out of business. Questions about testing standards, product safety requirements, and tax policy remain unresolved.
Some industry observers expect the state to consider structural reforms to the medical program. Potential changes could include higher barriers to entry for new licenses, revised residency requirements, or modified patient eligibility criteria.
The OMMA has not provided a timeline for naming Berry's replacement. In the interim, the agency's deputy director is expected to assume day-to-day operations.
For Oklahoma's remaining cannabis businesses, the leadership transition adds another layer of uncertainty to an already challenging market environment. Many operators are watching closely to see whether the state doubles down on enforcement or shifts toward policies that might stimulate growth.
This article is based on original reporting by mjbizdaily.com.